NEWSROOM
Press releases
October 27, 2021
Exothera announces the appointment of Hanna Lesch as Chief Technology Officer
September 9, 2021
GeneQuine selects Exothera to support the next stage of its osteoarthritis gene therapy development
July 1, 2021
Pall Corporation Secures Multi-Million Dollar Contract With Exothera
June 1, 2021
Univercells and Exothera announce Thibault Jonckheere as new CEO of Exothera
May 20, 2021
Codagenix and Univercells Announce Research Collaboration on Undisclosed, High-Priority Human Vaccine Target with Global Public Health Demand
March 24, 2021
CyanVac selects Exothera for the development and GMP manufacturing of its COVID-19 intranasal vaccine candidate for phase III clinical trial in Europe and the US
January 28, 2021
Exothera completes its range of state-of-the-art technologies by acquiring the new generation of the NevoLine™ Upstream platform for its new site in Belgium
